Nebulized Morphine in Chest Trauma Patients: A Prospective Study

Status Completed

Clinical Trial Summary

This is a prospective study carried out from 2018 to 2020 including patients aged ≥ 18 years, admitted for isolated chest trauma. Each patient received a nebulization of 10 mg morphine. If Visual Analog Score (VAS) assessed after 10 minutes still> 4, nebulization was repeated every 10 minutes until pain relief. At 30 minutes, VAS> 4 means failure.

Clinical Trial Description

The aim of this study was to determine the predictive factors of nebulized morphine failure in patients with chest trauma and to establish a score based on these factors to guide the analgesic protocol. Methods: This is a prospective study carried out from 2018 to 2020 including patients aged ≥ 18 years, admitted for isolated chest trauma. Each patient received a nebulization of 10 mg morphine. If Visual Analog Score (VAS) assessed after 10 minutes still> 4, nebulization was repeated every 10 minutes until pain relief. At 30 minutes, VAS> 4 means failure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03580187
Study type	Interventional
Source	University Hospital, Mahdia
Contact
Status	Completed
Phase	Phase 3
Start date	June 14, 2018
Completion date	April 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06236113` - Low Dose Ketamine for Blunt Thoracic Trauma	Phase 4
Active, not recruiting	`NCT01367951` - Treatment of Acute, Unstable Chest Wall Injuries	N/A
Not yet recruiting	`NCT05886946` - Abg in Blunt Chest Trauma
Recruiting	`NCT05527431` - High Flow Nasal Cannula vs Noninvasive Ventilation in Patients With Hypoxic Respiratory Failure Following Blunt Chest Trauma	N/A
Not yet recruiting	`NCT06316375` - STUMBL Score as a Risk Stratification Tool for Management of Blunt Chest Trauma Patients